FDA Risk Communication Plan May Be Released Within A Month
This article was originally published in The Gray Sheet
Executive Summary
FDA's strategic plan for ensuring the public receives accurate and balanced information about the risks and benefits of medical products could be released within a month, according to FDA Center for Drug Evaluation and Research Director Janet Woodcock
You may also be interested in...
FDA Aims To Improve Product Risk Communication Under Strategic Plan
Under a plan unveiled Sept. 30, FDA aims to increase its understanding of appropriate ways to communicate with the public about product risks and to streamline its product risk communication processes
FDA Aims To Improve Product Risk Communication Under Strategic Plan
Under a plan unveiled Sept. 30, FDA aims to increase its understanding of appropriate ways to communicate with the public about product risks and to streamline its product risk communication processes
When Communicating Product Risks, FDA Should Involve Firms – AdvaMed
AdvaMed is urging FDA to "routinely" consult with manufacturers when developing and evaluating safety-related communications about devices, drugs and other regulated products